Nav Close

NEOSENS is an AI-based technology that provides rapid and accurate health assessment from a single drop of blood.

NEOSENS ensures newborns in LMICs receive the best possible start in life. Our technology brings together two key approaches for detecting neonatal sepsis. Traditional methods rely on observing clinical signs and risk factors, while more modern techniques measure the levels of infection indicators (known as biomarkers) in the blood.

NEOSENS merges these two approaches. We provide a point-of-care device which provides a rapid and reliable analysis, based
on the detection of sepsis biomarkers in the infant. This is then complemented with our predictive model software which calculated an accurate sepsis score.

This dual-analysis method enables doctors to make quick decisions.